Theme: Emerging Technology and Advanced Research in Pharmaceutical sciences
Pharma Congress 2016
Pharma Congress 2016 welcomes you to attend the World Pharma Congress to be held during November 07-09, 2016 in Las Vegas, USA focuses on the Advanced Research in Pharmaceutical sciences.
In the light of this theme, the conference series aims to provide a forum for International researchers from various areas of Pharmacy, Medical, Health science and Life science by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Pharmaceutical Sciences.
Track 1: Pharmaceutical Drug development
A Drug is any substance other than food, that when inhaled, injected, smoked, consumed, absorbed via a patch on the skin or dissolved under the tongue causes a physiological change in the body. In Pharmacology, a Pharmaceutical drug or medicine, is a chemical substance used to treat, cure, prevent, diagnose a disease or promote well-being. Traditionally drugs were obtained through extraction from medicinal plants, but more recently also by organic synthesis. Pharmaceutical drugs may be used for a limited duration, or on a regular basis for chronic disorders.
Pharmaceutical drugs are often classified into drug classes—groups of related drugs that have similar chemical structures, the same mechanism of action (binding to the same biological target), a related mode of action, and that are used to treat the same disease. The Anatomical Therapeutic Chemical Classification System (ATC), the most widely used drug classification system, assigns drugs a unique ATC code, which is an alphanumeric code that assigns it to specific drug classes within the ATC system. Another major classification system is the Biopharmaceutics Classification System. This classifies drugs according to their solubility and permeability or absorption properties
Related Conferences:
Industrial Pharmacy Conference UAE, April 28-29, 2016, Dubai; Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain; Expo on Drug Discovery & Designing Oct 31-Nov 02, 2016 Istanbul, Turkey; Pharmaceutics and Novel Drug Delivery Systems March 13-15, 2016 London UK; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 2: Drug Discovery & Development
Drug Discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as classical Pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.
Related Conferences:
Indo-Global Summit & Expo on Veterinary October 26-28, 2015 Hyderabad, India; Annual European Pharma Congress June 18-20, 2016 Berlin, Germany; Annual Congress on Pharma Middle East October 10-12, 2016, Dubai, UAE; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 3: Drug Designing & Research
Drug design, sometimes referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modelling techniques. This type of modelling is often referred to as Computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design.
Related Conferences:
3rd International Conference on Clinical Pharmacy, Dec 07-09, 2015 Atlanta, USA; 5th Annual European Pharm Congress, Jun 13-15, 2016 Berlin, Germany; 2nd International Conference on Clinical Trials, Aug 22-24, 2016 Philadelphia, USA; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 4: Clinical Trials & Research Advancements
Clinical trials are experiments done in Clinical research. Such prospective biomedical or behavioural research studies on human participants are designed to answer specific questions about biomedical or behavioural interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on Safety and efficacy.They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial - their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
Related Conferences:
Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain, Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, Madrid, Spain, 07 March 2016- 09 March 2016, 2nd International Conference and Expo on Industrial Pharmacy April 24-25, 2017 Frankfurt, Germany, Pharma Marketing Conference November 17-19, 2016 Alicante, Spain; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 5: Bio Availability & Bio Equivalence
Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same.
The United States Food and Drug Administration (FDA) has defined bioequivalence as, "the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.
Related Conferences:
Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK ; Asia Pacific Drug Formulation & Bioavailability Congress, June 06-08, 2016, Beijing, China; Therapeutic Drug Monitoring and Toxic genomics , June 09-10, 2016, Dallas, USA; Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey, Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 6: Drug Formulation & Evalution Studies
Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.
Related Conferences:
Indo-Global Summit & Expo on Veterinary October 26-28, 2015 Hyderabad, India; 5th Annual European Pharma Congress June 18-20, 2016 Berlin, Germany; 8th Annual Congress on Pharma Middle East October 10-12, 2016, Dubai, UAE; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 7: Drug Delivery Systems
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic Pharmacokinetics in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
Related Conferences:
Pharmaceutical Regulatory Affairs and IPR Conference September 12-14, 2016 San Antonio, USA; Biologics and Biosimilar Conference September 12-14, 2016 San Antonio, USA: 2nd International Conference and Expo on Industrial Pharmacy April 24-25, 2017 Frankfurt, Germany, Pharma Marketing Conference November 17-19, 2016 Alicante, Spain; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 8: Regulatory Guidelines and Intellectual Property Rights
Intellectual Property (IP): For the purpose of this policy, “Intellectual Policy” is defined as the tangible or intangible results of research, development, teaching, or other intellectual activity. Intellectual property may include the following products:
- Patents on new and useful scientific or technical advancements by way of inventions, discoveries, processes, computer hardware and software, unique materials, machines, devices, instruments, apparatuses, circuits, plant varieties etc.
- Copyright in industrial and architectural design, models, engineering drawings, integrated circuit layout designs, computer software, animations and visualizations, information technology products and processes including hardware and software features, original innovative, creative or artistic works and their derivatives or adaptations, whether dramatic, musical, literary works, work of graphics or plastics art and cinematographic and animated films, teaching material for classroom and online courses such as courseware for distance education, original data and records of research, undisclosed and/or unpublished information etc.
- Trademarks, service marks, logos, collective marks, certification marks, trade names etc.
Related Conferences:
3rd International Conference on Clinical Pharmacy, Dec 07-09, 2015 Atlanta, USA; 7th 5th Annual European Pharm Congress, Jun 13-15, 2016 Berlin, Germany; 2nd International Conference on Clinical Trials, Aug 22-24, 2016 Philadelphia, USA; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 9: Supply Chain Managements
Supply Chain Management (SCM) is the management of the flow of goods and services. It includes the movement and storage of raw materials, work-in-process inventory, and finished goods from point of origin to point of consumption. Interconnected or interlinked networks, channels and node businesses are involved in the provision of products and services required by end customers in a supply chain. Supply chain management has been defined as the "design, planning, execution, control, and monitoring of supply chain activities with the objective of creating net value, building a competitive infrastructure, leveraging worldwide logistics, synchronizing supply with demand and measuring performance globally.
Related Conferences:
2nd International Conference and Expo on Industrial Pharmacy April 24-25, 2017 Frankfurt, Germany, Pharma Marketing Conference November 17-19, 2016 Alicante, Spain; Pharmaceutical Regulatory Affairs and IPR Conference September 12-14, 2016 San Antonio, USA; Biologics and Biosimilar Conference September 12-14, 2016 San Antonio, USA: Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 10: Documentation
Documentation is a set of documents provided on paper, or online, or on digital or analog media, such as audio tape or CDs. Examples are user guides, white papers, on-line help, quick-reference guides. It is becoming less common to see paper (hard-copy) documentation. Documentation is distributed via websites, software products, and other on-line applications.
Related Conferences:
Indo-Global Summit & Expo on Veterinary October 26-28, 2015 Hyderabad, India; 5th Annual European Pharma Congress June 18-20, 2016 Berlin, Germany; 8th Annual Congress on Pharma Middle East October 10-12, 2016, Dubai, UAE; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
Track 11: Biosimilars & Research Developments
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.
Related Conferences:
3rd International Conference on Clinical Pharmacy, Dec 07-09, 2015 Atlanta, USA; 7th 5th Annual European Pharm Congress, Jun 13-15, 2016 Berlin, Germany; 2nd International Conference on Clinical Trials, Aug 22-24, 2016 Philadelphia, USA; Academy of Managed Care Pharmacy, American Association of Colleges of Pharmacy, American Association of Pharmacy Technicians, American Society for Clinical Pharmacology and Therapeutics , American Society of Consultant Pharmacists, American Society of Pharmacognosy, Austrian Association of Hospital Pharmacists.
On behalf of Pharma Congress 2016, organizing committee invites analytical expertise researchers, professors, scientific communities, delegates, students, business professionals and executives to attend the “World Pharma Congress” which is to be held during Nov 07-Nov 09, 2016 Las Vegas, Neveda, USA
In the light of this theme, the conference series aims to provide a forum for International researchers from various areas of Pharmacy, Medical, Health science and Life science by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of pharmacy.
The conferences provide a platform to detail the research work of expertise from various scientific backgrounds and the same can be perceived by young researchers and students. The conference mainly aims to provide knowledge on Pharmacy and unveil the roles and responsibilities of pharmacist. In course of research work and therefore World Pharma Congress 2016 would be a perfect venue to share and develop knowledge on Pharmacy.
The pharmaceutical Industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. The total level of pharmaceutical revenue worldwide had reached nearly one trillion U.S. dollars. North America is responsible for the largest portion, generating more than 40 percent of these revenues. This is mostly due to the leading role of the U.S. pharmaceutical industry. But as in many other industries, the Chinese pharmaceutical sector shows the highest growth rates over the last years. The global pharmaceuticals market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. Further, incidence of chronic conditions in the developing world will increasingly resemble those of the developed world.
Why to attend ?
As Pharmaceutical care moves to a more patient centred model it becomes extremely important to ensure an adequate and professional pharmacy practice. Pharmacists, in one hand, need to ensure maximum use of their skills by embarking on a culture of lifelong learning. On the other hand, it becomes evident that all members of the healthcare system need to co-operate to ensure planning, implementation and monitoring of a therapeutic plan that focuses on effective patient outcome. International pharmacy conference reinforces the importance of collaboration and dialogue between Policy Makers, Stakeholders, Regulators and Pharmaceutical experts.
Target Audience:
Students, Scientists, Researchers, and Faculty of pharmaceutical Universities, Medical colleges, Researchers from pharmaceutical Companies, Pharmacy associations and societies, Business Entrepreneurs, Training institutes, Software developing companies, Manufacturing medical devices companies, CRO and Data Management companies
The United States is a one of developed country and has the world's largest economy by nominal and real GDP, benefiting from an abundance of natural resources and high worker productivity. While the U.S. economy is considered post-industrial, the country continues to be one of the world's largest manufacturers as well as leader in scientific research and technological innovations. USA having 7-8 associations related to heart diseases so scope is more there, is working hard to combat childhood obesity throughout the state, which can be leads to Heart diseases. USA has many cities so research work and institute are more there.
In Las Vegas, Las Vegas, officially the City of Las Vegas, is a city in the United States. It is the most populous
The pharmaceutical Industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. The total level of pharmaceutical revenue worldwide had reached nearly one trillion U.S. dollars. North America is responsible for the largest portion, generating more than 40 percent of these revenues. This is mostly due to the leading role of the U.S. pharmaceutical industry. But as in many other industries, the Chinese pharmaceutical sector shows the highest growth rates over the last years. The global pharmaceuticals market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. Further, incidence of chronic conditions in the developing world will increasingly resemble those of the developed world.
Importance and scope: With the development of specific and potent synthetic drugs, the emphasis of the pharmacist’s responsibility has moved substantially towards the utilization of scientific knowledge in the proper use of modern medicines and the protection of the public against dangers that are inherent in their use. Pharmacists are employed in regulatory control and drug management, community pharmacy, hospital pharmacy, the pharmaceutical industry, academic activities, training of other health workers, and research. In all these fields, their aim is to ensure optimum drug therapy, both by contributing to the preparation, supply and control of medicines and associated products, and by providing information and advice to those who prescribe or use pharmaceutical products.
Conference Highlights:
- Pharmaceutical Drug Development
- Drug Discovery & Research
- Clinical Trials & Research Advancements
- Novel Drug Delivery System
- Bio Availability and Bioequivalence
- Drug Formulation & Evaluation
- Drug Delivery Systems & Metabolism
- Regulatory Affairs and Intellectual Property Rights
- Documentation
- Pharmaceutical Analysis
- Biosimilars & Research Developments
- Drug Safety
- Pharmacovigilance
- Data Integrity in Pharma
- Advances In Pharmacological Research
- Adverse Drug Reactions
- Bio and Chemoinformatics
- Entrepreneurs Investment Meet
North America – outlooks for leading generic drug producers and sellers
First our report analyses 13 North American generics specialists and big pharma companies in that market, including these firms:
• Mylan
• Pfizer
• Abbott
• Hospira
• Apotex
• Par Pharmaceuticals.
In that analysis you find where revenue growth occurs and how high sales can go. Many opportunities remain, with high, expanding revenues possible from 2015.
Europe – prospects for leading generics players
Our survey also shows you outlooks for 10 European generics specialists and pharmaceutical leaders in that industry, including these firms:
• Novartis (Sandoz)
• Actavis
• Sanofi
• Fresenius Kabi
• Pharmstandard
• Gedeon Richter
• Stada Arzneimittel.
Conference Highlights
- Pharmaceutical Drug Development
- Drug Discovery & Research
- Clinical Trials & Research Advancements
- Bio Availability and Bioequivalence
- Drug Formulation & Evaluation
- Drug Delivery Systems & Metabolism
- Regulatory Affairs and Intellectual Property Rights
- Documentation
- Pharmaceutical Analysis
- Biosimilars & Research Developments
- Novel Drug Delivery System
- Drug Safety
- Pharmacovigilance
- Advances In Pharmacological Research
- Adverse Drug Reactions
- Bio and Chemoinformatics
- Entrepreneurs Investment Meet
- Data Integrity in Pharma
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
| Conference Date | Nov 07-09, 2016 | ||
| Sponsors & Exhibitors |
|
||
| Speaker Opportunity Closed | Day 1 | Day 2 | |
| Poster Opportunity Closed | Click Here to View | ||
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- Journal of Pharmaceutical Care & Health Systems
- Clinical Pharmacology & Biopharmaceutics
- Journal of Developing Drugs
Abstracts will be provided with Digital Object Identifier by
